(Press-News.org) Helen E. Davies, M.D., of the University Hospital of Wales, Cardiff, and colleagues compared the effectiveness of treatments to relieve breathing difficulties among patients with malignant pleural effusion (presence of fluid in the pleural cavity [space between the outside of the lungs and the inside wall of the chest cavity], as a complication of malignant disease). The treatments compared were chest tube drainage and talc slurry for pleurodesis (a procedure in which the pleural space is obliterated) vs. indwelling pleural catheters (IPCs).
Malignant pleural effusion causes disabling dyspnea (breathing difficulties) in more than 1 million people worldwide annually; patients have an average life expectancy of 4 months. "There are no robust clinical data to address which of these treatments is more effective at palliating symptoms and improving quality of life," the authors write. "Indwelling pleural catheters are increasingly used as an alternative treatment to talc pleurodesis."
The randomized controlled trial compared IPC (n = 52) and talc slurry for pleurodesis (n = 54) for patients with malignant pleural effusion who were treated at 7 U.K. hospitals. Patients were screened from April 2007-February 2011 and were followed up for a year. The researchers found that there was no significant difference between groups in dyspnea in the first 42 days after intervention. Indwelling pleural catheters reduced time in the hospital but were associated with an excess of adverse events. "As such, IPCs cannot be advocated as a superior treatment to talc pleurodesis for palliation of symptoms," the authors write.
###(doi:10.1001/JAMA. 2012.5535. Available pre-embargo to the media at http://media.jamanetwork.com)
To contact corresponding author Najib M. Rahman, D.Phil., email najib.rahman@ndm.ox.ac.uk.
Study examines treatments for relieving breathing difficulties among patients with lung effusions
2012-05-21
ELSE PRESS RELEASES FROM THIS DATE:
Low-dose CT screening may benefit individuals at increased risk for lung cancer
2012-05-21
Peter B. Bach, M.D., of the Memorial Sloan-Kettering Cancer Center, New York, and colleagues conducted a systematic review to examine the evidence regarding the benefits and harms of low-dose computerized tomography (LDCT) screening for lung cancer, which is the leading cause of cancer death. "Most patients are diagnosed with advanced disease, resulting in a very low 5-year survival rate," the authors write. "Renewed enthusiasm for lung screening arose with the advent of LDCT imaging, which is able to identify smaller nodules than can chest radiographs."
For the review, ...
Study evaluates use of inhaled saline for young children with cystic fibrosis
2012-05-21
Margaret Rosenfeld, M.D., M.P.H., of Seattle Children's Hospital, and colleagues conducted a study to examine if hypertonic saline would reduce the rate of pulmonary exacerbations in children younger than 6 years of age with cystic fibrosis (CF). Inhaled hypertonic saline is recommended as therapy for patients 6 years or older with CF, but its efficacy has not been evaluated in patients younger than 6 years.
In the randomized trial, the active treatment group (n = 158) received 7 percent hypertonic saline and the control group (n = 163) received 0.9 percent isotonic saline, ...
Songbirds' learning hub in brain offers insight into motor control
2012-05-21
To learn its signature melody, the male songbird uses a trial-and-error process to mimic the song of its father, singing the tune over and over again, hundreds of times a day, making subtle changes in the pitch of the notes. For the male Bengalese finch, this rigorous training process begins around the age of 40 days and is completed about day 90, just as he becomes sexually mature and ready to use his song to woo females.
To accomplish this feat, the finch's brain must receive and process large quantities of information about its performance and use that data to precisely ...
Scientists identify new target to battle rheumatoid arthritis
2012-05-21
A new study led by researchers at Hospital for Special Surgery identifies the mechanism by which a cell signaling pathway contributes to the development of rheumatoid arthritis (RA). In addition, the study provides evidence that drugs under development for diseases such as cancer could potentially be used to treat RA. Rheumatoid arthritis, a systemic inflammatory autoimmune disease that can be crippling, impacts over a million adults in the United States.
"We uncovered a novel mechanism by which the Notch pathway could contribute to RA, said Xiaoyu Hu, M.D., Ph.D., a ...
Flavia Del Monte Launches New Targeted Metabolic Workout Program, Curvalicious
2012-05-21
Internationally recognized fitness enthusiast, Flavia Del Monte, has spent years helping women learn how their bodies work, proper nutrition for women and how to exercise in a way that benefits women. As the founder of Flavilicious Fitness she has been creating workout and nutrition programs specifically designed for the needs of women.
Flavia Del Monte's newest workout and nutrition program, Curvalicious, is the first to target metabolic fat loss while increasing both Myogenic and Neurogenic muscle tone. Myogenic muscle tone is the residual tension in a muscle at rest. ...
Discovery of mechanisms predicting response to new treatments in colon cancer
2012-05-21
Barcelona, 20 May 2012. The Stem Cells and Cancer Research Group headed by Dr Héctor G. Palmer at the Vall d'Hebrón Institute of Oncology (VHIO) has identified the molecular mechanisms that determine patients' response to certain drugs used in clinical trials for colon cancer treatment. The study led by VHIO also benefited from the collaboration with Professor Alberto Muñoz´s laboratory at the Instituto de Investigaciones Biomedicas Alberto Sols, Consejo Superior de Investigaciones Científicas (IIB-CSIC-Madrid). Published today in Nature Medicine, this work identifies biomarkers ...
Blocking DNA: HDAC inhibitor targets triple negative breast cancer
2012-05-21
The histone de-acetylase (HDAC) inhibitor panobinostat is able to target and destroy triple negative breast cancer, reveals a new study published in BioMed Central's open access journal Breast Cancer Research. Researchers from Tulane University Health Sciences Center have shown that panobinostat was able to destroy breast cancer cells and reduce tumor growth in mice.
Approximately 15% of breast cancers are found at diagnosis to be triple negative. These aggressive tumours are missing both the estrogen receptor and progesterone receptor, which means that they do not respond ...
ApparelUS.com, Wholesale Apparel Retailer, is Now Offering Discounts of Up to 60 Percent on All Clothing
2012-05-21
Finding the right clothes at the right price can be an inconvenient chore for those that do not know where to look. It will not take much to be forced to overpay, especially when on the search for wholesale apparel that is stylish and fashion forward. With some of the huge discounts of up to 60 percent now offered by the leading wholesale clothing retailer, ApparelUS.com, customers are now finding the outfits that they need while staying within their budget.
Purchasing wholesale clothes in person can turn into a lengthy ordeal with pushy salespeople and second-rate items. ...
Soldiers who desecrate the dead see themselves as hunters
2012-05-21
Modern day soldiers who mutilate enemy corpses or take body-parts as trophies are usually thought to be suffering from the extreme stresses of battle. But, research funded by the Economic and Social Research Council (ESRC) shows that this sort of misconduct has most often been carried out by fighters who viewed the enemy as racially different from themselves and used images of the hunt to describe their actions.
"The roots of this behaviour lie not in individual psychological disorders," says Professor Simon Harrison who carried out the study, "but in a social history ...
Scientists discover distinct molecular subtype of prostate cancer
2012-05-21
NEW YORK, CAMBRIDGE, Mass., AND BOSTON (May 20, 2012) -- A collaborative expedition into the deep genetics of prostate cancer has uncovered a distinct subtype of the disease, one that appears to account for up to 15 percent of all cases, say researchers at Weill Cornell Medical College, the Broad Institute of MIT and Harvard and the Dana-Farber Cancer Institute.
In the study, published online May 20 by the journal Nature Genetics, investigators describe how they discovered novel mutations in the SPOP ("S-pop") gene in numerous patient tumors, saying this alteration is ...